Pharmacokinetic and Pharmacodynamic Properties of the Calcimimetic Agent Cinacalcet (KRN1493) in Healthy Male Korean Subjects: A Randomized, Open-Label, Single Ascending–Dose, Parallel-Group Study-Reference-Cited by-同舟云学术

Pharmacokinetic and Pharmacodynamic Properties of the Calcimimetic Agent Cinacalcet (KRN1493) in Healthy Male Korean Subjects: A Randomized, Open-Label, Single Ascending–Dose, Parallel-Group Study

Published:2012-05 Issue:5 Volume:34 Page:1160-1169
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Lee SeungHwan,Gu Namyi,Kim Bo-Hyung,Lim Kyoung Soo,Shin Sang-Goo,Jang In-Jin,Yu Kyung-Sang

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Hyperparathyroidism;Fraser;Lancet,2009

2. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics;Goodman;Kidney Int,2008

3. Renal bone disease;Sprague;Curr Opin Endocrinol Diabetes Obes,2010

4. Achieving therapeutic targets in the treatment of secondary hyperparathyroidism;Cunningham;Nephrol Dial Transplant,2004

5. Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials;Goodman;Pediatr Nephrol,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effects of calcitriol and calcimimetic on bone health in renal insufficiency;The FASEB Journal;2024-06-07

2. Oral cinacalcet administration decreases serum ionized calcium and parathyroid hormone concentrations in healthy dogs;Journal of Veterinary Pharmacology and Therapeutics;2024-04-02

3. Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism;Journal of Medicinal Chemistry;2023-07-13

4. Development and validation of an LC-MS/MS method by one-step precipitation for cinacalcet in human plasma;Heliyon;2023-06

5. Development and validation of a quantitative assay for the determination of cinacalcet and its main metabolites in human plasma using RP-HPLC method;Microchemical Journal;2017-01